Tip sheet on how to manage psoriatic disease when planning to have a family from parents to future parents.
Advancements in Treating Moderate-to-Severe Plaque Psoriasis
27 November 2023
By UCB
Bimekizumab provides a rapid and long-term response in patients with moderate-to-severe plaque psoriasis. At the (EADV) 2023 Congress, three posters were presented reporting 3-year results from the Phase III/IIIb clinical trials of Bimekizumab.
Related content
Article from EUROPSO raises important points to remember when women are planning to have children.
Article Stigma, Care and Treatment
Advocating for Family Well-being in Psoriatic DiseaseArticle Stigma, Care and Treatment
Recommendations for Health Care ProfessionalsArticle Stigma, Care and Treatment
Family Well-Being in Psoriatic Disease - Caring for the CaregiverThe Impact of Psoriatic Disease on a Woman’s Career, Family Planning, Social Life and Mental: results from a 2021 survey on women living in Europe.
News Latest Research, Care and Treatment
PsOlve: Open call to join the Innovation Challenge to improve holistic management and long-term wellbeing of people living with psoriasis